Mengdong He, MHS

UCLA David Geffen School of Medicine
Los Angeles, CA, United States

Research trainee at BWH; Medical student at UCLA DGSOM

Disclosure information not submitted.

Presentation(s):

• 0925: Impact of Initiating Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs on Pain Medication Use in Patients with Rheumatoid Arthritis

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 0925: Impact of Initiating Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs on Pain Medication Use in Patients with Rheumatoid Arthritis

  Monday, November 14, 2022
  1:20 PM – 1:25 PM Eastern Time